Posted by: Audrey Erbes | April 6, 2014

Landmark Obamacare Enrollment Reached plus Events and Jobs

I’ve sat in amagement at how some critics of Obamacare continue to discredit the plan and some Congressmen have even tried to overturn the law 52 times even in the face of the Supreme Court decision. My take on this is that half of the public is gullible enough to believe their spokespeople’s scare tactics even when the statements that underlay their criticism are untrue. The issue still makes for a good rallying call for politicians organizing people who share their beliefs to gain votes in 2014 elections even though they may have individually accepted the inevitability of the new law.

Those of us in the health care industry have known for a long time that the system is broken and that there can’t be unlimited, escalating costs for a care system that isn’t serving our citizen patients very well. Of course, there needs to be changes to get the costs under control and some of those changes will threaten industry’s bread and butter as well. The smart companies recognize that changes are inevitable and will research the changes and potential scenarios and survive.

Citizens want improved health care but many won’t invest in the time to research the issues or perhaps know where to find accurate information. They want to believe the media that they gravitate to even if it tells them that killing Obamacare is in their interest. They are looking for a simple answer for an admittedly a very complex subject. The average citizen isn’t alone in wondering how all the related policies will work out and the impact on them. Just as many develop conspiracy theories when they don’t have access to correct information as in the case of the missing Malaysian airliner, many are subject to scare tactics about the unknown in the face of major changes of any kind. I imagine any political discussion of a serious reform of the tax code would be even more difficult?

Obamacare is a big change and there will be many adjustments to be made not just by patients, but by physicians and industry. It will just take time to resolve the scariness for all. Americans survived the introduction of Social Security, Medicare, Part D drug coverage and now will survive Obamacare, but the rhetoric will likely continue. There was a lot of negative criticism prior to their acceptance.

I’m heartened by the enrollment reaching 7 million at the end of March 31st. Just as those who support the politicians who want to slash budgets for health care but don’t want their Medicare benefits touched also don’t want to return to lack of coverage for preexisting conditions, the slashing of care for their children and taking away coverage for their adult children under 26 under their policies. Politics aren’t always rational but the public is enrolling in keeping with their interest even when some of them are going against the rhetoric of their political icons.

Highlights for The Coming Weeks Bay Area Events

  • BioCentury This Week, See new program Webcast Starting Sunday, April 6, 2014,, Available anytime starting at 9:00 a.m. EDT; Topic: “The New IPO Age: Onward and Upward;” Speakers: Jeffrey Abbey of Argos Therapeutics Inc; Dr. Scott Koenig of MacroGenics Inc.; and Tim Mayleben of Esperion Therapeutics Inc.
  • Bay Area Medical Device Group, Monday Evening, April 7, 2014; Event: Bay Area Medical Device Networking
  • UC Berkeley Extension, Monday – Friday, April 7-11, 2014; Course: “Bioscience Essentials for Industry Professionals: An Intensive Seminar” MCELLBI 1001
  • Bio2Device Group, Tuesday Evening, April 8, 2014; Topic: “Coming Out of the Dark Ages of Stroke Healthcare;” Speaker: Dr. Mark Borsody, Chief Medical Officer, Nervive Inc.
  • SF AWIS, Wednesday Evening, April 9, 2014; Topic: “Science and Sustainability;” Speaker: Jill Kauffman-Johnson, Director of Sustainability at Solazyme, Inc.
  • UC Berkeley Extension Course, Thursday and Friday, April 10-11, 2014; Course: “Life Science Business and Marketing: Their Integral Role for Success”

All registered students will have free access to Elsevier’s premier licensing/deal database Strategic Transactions covering all industry sectors plus In Vivo, Start Up, Medtech Insight, and The RPM Report during two month period following intensive classroom work. It’s an opportunity to do a project with guidance from the instructor and gain access to these great resources in addition to extensive listing of online resources developed by the instructor. You can locate course online and register at

  • Janssen Labs, Thursday Mid-Day, April 10, 2014; Topic: “Social Media 101: How to Raise Your Company’s Voice;” Speaker: Barbara Lavery | President, Zoomedia


Find all the details for this coming week’s upcoming events plus those through June 2014 in Audreys picks April 6, 2014. You can download the pdf of JobsThatCrossedMyDeskThrough April 6, 2014 along with Audrey’s Picks by right clicking on the highlighted titles. This latter list includes the latest three weeks of positions.


You can always find my weekly blog and listings at





  1. Reblogged this on 12081986.

  2. Hi Audrey – Will you let your network know about the DxMA (Diagnostic Marketing Association) Global Summit next week in SF? The President of Genomic Health will be speaking as well as the CEO of Cermed, and Marketing Directors from Natera and Roche Diagnostics are also presenting. There are topics covering Marketing, Regulatory, Affordable Care Act, Best Practices and Trends.

    Thanks! Molly Crawley

    • Sorry I missed your note in time to promote, Molly.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s


%d bloggers like this: